Mark Nawacki

Mark Nawacki is the President of Searchlight Pharma, Apotex’s specialty pharmaceutical division. Mark co-founded Searchlight Pharma having spent his career building businesses through acquisition, licensing and business development leadership.

Mark has wide-ranging experience in the pharmaceutical industry in Canada and internationally. Under his guidance, the acquisitions of Miravo Healthcare, Erfa Canada, and Besins Healthcare Canada, as well as over 20 external partnering transactions, have grown Searchlight Pharma into a fast-growing and profitable Canadian industry leader.

Mark is a past member of the Board of Trustees of the Licensing Executive Society (USA & Canada) and is a former President and Board Member of the Canadian Healthcare Licensing Association. Mark has also been a past board member and chair of the board of Kane Biotech (TSXV: KNE) on the board of Litha Healthcare from 2012 to 2014. He currently sits on the Board of Intelgenx Technologies Corp. (TSX:IGX), where he serves as chair of the compensation committee.

Mark holds a BA in International Relations and Russian and East European Studies from the University of Toronto (Trinity), an MBA also from the University of Toronto, and is a current member of the Chartered Professional Accountants of Ontario (CPA Ontario).